LENSAR, Inc.

LENSAR, Inc. is a medical device company based in Orlando, Florida, that specializes in advanced femtosecond laser systems for refractive cataract surgery and astigmatism management. Founded in 2004 or 2005, LENSAR has developed its technology through extensive research and clinical trials, receiving FDA clearance for its LENSAR Laser System in 2010. The company has launched several iterations of its systems, including the Streamline II System in 2015, and is recognized for its innovative robotic laser technology. The company's core product, the ALLY Robotic Cataract Laser Treatment System™, features advanced imaging and AI-driven software to enhance surgical precision and efficiency. LENSAR sells its laser systems and related products directly to ophthalmic surgeons worldwide, focusing on meeting their needs through continuous technological advancements. With a growing international presence, LENSAR holds a notable market share in femtosecond laser cataract systems and is led by CEO Nicholas T. Curtis.